[1] Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol 2018;35(6):1547 − 9. http://dx.doi.org/10.1093/molbev/msy096CrossRef
[2] Li ZC, Nie K, Li KB, Hu Y, Song Y, Kang M, et al. Genome characterization of the first outbreak of COVID-19 delta variant B. 1. 617. 2 — Guangzhou City, Guangdong Province, China, May. China CDC Wkly 2021(27):587 − 9. http://dx.doi.org/10.46234/ccdcw2021.151CrossRef
[3] European Centre for Disease Prevention and Control. Implications for the EU/EEA on the spread of the SARSCoV-2 delta (B. 1.617. 2) variant of concern - 23 June 2021. ECDC: Stockholm. 2021. https://www.ecdc.europa.eu/sites/default/files/documents/Implications-for-the-EU-EEA-on-the-spread-of-SARS-CoV-2-Delta-VOC-23-June-2021_2.pdf.[2021–08–14].https://www.ecdc.europa.eu/sites/default/files/documents/Implications-for-the-EU-EEA-on-the-spread-of-SARS-CoV-2-Delta-VOC-23-June-2021_2.pdf
[4] Campbell F, Archer B, Laurenson-Schafer H, Jinnai Y, Konings F, Batra N, et al. Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021. Euro Surveill 2021;26(24):2100509. http://dx.doi.org/10.2807/1560-7917.ES.2021.26.24.2100509CrossRef
[5] Scientific Advisory Group for Emergencies. SPI-M-O: consensus statement on COVID-19, 3 June 2021. GOV. UK. 2021. https://www.gov.uk/government/publications/spi-m-o-consensus-statement-on-covid-19-3-june-2021.[2021-08-14].https://www.gov.uk/government/publications/spi-m-o-consensus-statement-on-covid-19-3-june-2021
[6] Planas D, Veyer D, Baidaliuk A, Staropoli I, Guivel-Benhassine F, Rajah MM, et al. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature 2021;596(7871):276 − 280. http://dx.doi.org/10.1038/s41586-021-03777-9CrossRef
[7] Liu C, Ginn HM, Dejnirattisai W, Supasa P, Wang BB, Tuekprakhon A, et al. Reduced neutralization of SARS-CoV-2 B. 1. 617 by vaccine and convalescent serum. Cell 2021;184(16):4220 − 36.e13. http://dx.doi.org/10.1016/j.cell.2021.06.020CrossRef